Financials
- Market Capitalization 2.32 B
- Employee 890
- Founded 1996
- CEO Matthew M. Mannelly
- Website www.prestigebrands.com
- Headquarter New York, United States
- FIGI BBG000QM0RZ4
- Industry Fabricants de Médicaments — Spécialités et Génériques
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
15.16
ratio cours/chiffre d'affaires
2.79
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1776 | SUPN Supernus Pharmaceuticals, Inc. - Common Stock | 47.35 USD | -2.29% | -0.80% | +6.74% | -12.31% | 2.75 B USD | ||
| 1848 | RGC Regencell Bioscience Holdings Limited - Ordinary Shares | 5.05 USD | -14.12% | -8.35% | -73.18% | -64.39% | 2.50 B USD | ||
| 2007 | HCM HUTCHMED (China) Limited - American Depositary Shares | 11.14 USD | +0.63% | -3.05% | +2.30% | -31.95% | 1.94 B USD | ||
| 2049 | ANIP ANI Pharmaceuticals, Inc. - Common Stock | 81.08 USD | -1.21% | -5.93% | -1.27% | -14.32% | 1.84 B USD |